ResMed Inc (ASX: RMD)

RMD:NYQ, also known as Resmed Inc., produces medical devices and software for the healthcare market. ResMed has recently completed two acquisition deals. On September 29, 2023, they finalized the purchase of KC Machine LLC, acquiring a 44.51% stake in the company at a transaction value of $2.60 million. The second deal completed was with Somnoware Healthcare Systems Inc on July 5, 2023, although the percentage acquired and the transaction value were not disclosed.

As of the last recorded data on December 31, 2023, First Sentier Investors (Hong Kong) Ltd. held 9.55 million shares in Resmed Inc., representing a 0.65% stake. Following closely, Vanguard Investments Australia Ltd. owned 8.72 million shares, accounting for 0.59% as of March 31, 2024. Schroder Investment Management (Singapore) Ltd. held 5.61 million shares (0.38%) as of January 31, 2024. Australian Foundation Investment Co. Ltd. (Investment Management) reported a 0.30% stake with 4.39 million shares as of June 30, 2023. Lastly, First Sentier Investors (Australia) IM Ltd. held 4.26 million shares, a 0.29% stake as of December 31, 2023. Additional shareholding is noted from FIL Investment Management (Singapore) Ltd. with 3.38 million shares representing 0.23%.

Financial details such as the income statement for Resmed Inc. are currently unavailable. The company offers tools such as a Growth Calculator Beta to explore financial concepts like the time value of money and the benefits of saving over time. For those interested in monitoring financial markets and events, features like Alerts for immediate notifications and the option to create Watchlists for a curated list of assets are available.

Top Australian Brokers

City Index - Aussie shares from $5 - Read our review
Pepperstone - Trading education - Read our review
IC Markets - Experienced and highly regulated - Read our review
eToro - Social and copy trading platform - Read our review